Popular on s4story


Similar on s4story

Promontory Therapeutics to Participate in Business Development Strategies Panel at the Sachs 9th Annual Immuno-Oncology Innovation Forum

S For Story/10587874
NEW YORK, May 31, 2023 ~ Promontory Therapeutics Inc., a clinical stage pharmaceutical company, will be participating in the Sachs 9th Annual Immuno-Oncology Innovation Forum on June 2, 2023 in Chicago. Matthew Price, EVP & COO of Promontory Therapeutics, will be part of the Business Development Strategies Panel to discuss how to maximize value in a capital efficient manner. Johan Baeck, CMO of Promontory Therapeutics, will also provide a presentation on the company's corporate and clinical progress with lead therapeutic candidate PT-112. The presentation will take place at 11:00am CDT in Room Faulkner at the Waldorf Astoria Hotel. For more information about the event and agenda, visit the Sachs Forum website.

More on S For Story
Filed Under: Business

Show All News | Report Violation

0 Comments

Latest on S For Story